Goodwin Biotechnology
PLANTATION, FL · Biotechnology, Health Care · 88 employees
Goodwin Biotechnology is a comprehensive Single Source Solution provider, offering a wide range of services, including cell line development, GMP master cell banking, proof-of-concept development, cell culture, purification, and bioconjugation process development, scale-up, GLP pilot manufacturing for toxicology animal studies, and cGMP manufacturing with fill & finish for human clinical trials.
Funding history
- Series seed — $2.0M — Jan 2026
- Series seed — $3.0M — Nov 2024
- Funding Round — $5.0M — Oct 2023
- Funding Round — $20.7M — Apr 2019
Recent signals
- Jan 27, 2026: Raised $2.0M in Series seed
- Nov 20, 2024: Launched GBI Biomanufacturing expands its capabilities with automated aseptic filling and finishing for pharmaceutical products.
- Nov 12, 2024: Raised $3.0M in Series seed
- Oct 02, 2023: Raised $5.0M
- Apr 30, 2019: Raised $20.7M
See plans & pricing → Track Goodwin Biotechnology’s funding, hiring, and signals — with verified contacts — on Fundz.